Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-5038
Publication type: | Conference poster |
Type of review: | Peer review (abstract) |
Title: | Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland |
Authors: | Mattli, Renato Eichler, Klaus Pletscher, Mark Wieser, Simon |
DOI: | 10.21256/zhaw-5038 |
Conference details: | ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013 |
Issue Date: | 2013 |
Publisher / Ed. Institution: | ZHAW Zürcher Hochschule für Angewandte Wissenschaften |
Language: | English |
Subject (DDC): | 362.1041: Health economics 362.11: Hospitals and related institutions |
Abstract: | Febrile neutropenia (FN) can be a serious complication of chemotherapy (CHT), increasing mortality risk and healthcare costs. Incidence and inpatient hospital costs of FN in Switzerland are currently not reported. The study aimed to: 1. Estimate the number of CHT induced FN-related hospitalizations. 2. Assess inpatient hospital costs per FN event in Switzerland. |
URI: | https://digitalcollection.zhaw.ch/handle/11475/15874 |
Fulltext version: | Published version |
License (according to publishing contract): | Licence according to publishing contract |
Departement: | School of Management and Law |
Appears in collections: | Publikationen School of Management and Law |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2013_Mattli_Inpatient_hospital_costs_of_febrile_neutropenia_as_a_consequence_of_chemotherapy.pdf | 102.67 kB | Adobe PDF | View/Open |
Show full item record
Mattli, R., Eichler, K., Pletscher, M., & Wieser, S. (2013). Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland. ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013. https://doi.org/10.21256/zhaw-5038
Mattli, R. et al. (2013) ‘Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland’, in ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. Available at: https://doi.org/10.21256/zhaw-5038.
R. Mattli, K. Eichler, M. Pletscher, and S. Wieser, “Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland,” in ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013, 2013. doi: 10.21256/zhaw-5038.
MATTLI, Renato, Klaus EICHLER, Mark PLETSCHER und Simon WIESER, 2013. Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland. In: ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013. Conference poster. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. 2013
Mattli, Renato, Klaus Eichler, Mark Pletscher, and Simon Wieser. 2013. “Inpatient Hospital Costs of Febrile Neutropenia as a Consequence of Chemotherapy for Breast Cancer and Non-Hodgkin Lymphoma in Switzerland.” Conference poster. In ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. https://doi.org/10.21256/zhaw-5038.
Mattli, Renato, et al. “Inpatient Hospital Costs of Febrile Neutropenia as a Consequence of Chemotherapy for Breast Cancer and Non-Hodgkin Lymphoma in Switzerland.” ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013, ZHAW Zürcher Hochschule für Angewandte Wissenschaften, 2013, https://doi.org/10.21256/zhaw-5038.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.